License-Out
License Agreement Has Been Entered into with xFOREST Therapeutics
We have executed an exclusive license agreement with xFOREST Therapeutics ( Kyoto city, Japan ) to conduct development and marketing of prod...
results 11 - 20 of 87
License-Out
License Agreement Has Been Entered into with T&R Biofab Co., Ltd.
We have executed a non-exclusive license agreement with T&R Biofab Co., Ltd. (Gyeonggi-do, Republic of Korea) for allowing them to provi...
License-Out
License Agreement Has Been Entered into with Elixirgen Scientific, Inc.
We have executed a non-exclusive license agreement with Elixirgen Scientific, Inc. (Baltimore, MD, U.S.A.) for allowing them to sell iPS ce...
License-Out
License Agreement Has Been Entered into with R&D Systems, Inc.
We have executed a non-exclusive license agreement with R&D Systems, Inc. (a Bio-Techne Corporation brand; Minnesota, U.S.A.) for allowi...
License-Out
License Agreement has been entered into with StrideBio Inc.
We executed a non-exclusive license agreement for internal research with StrideBio Inc.(North Carolina, U.S.A.) to access iPS cell related t...
License-Out
License Agreement has been entered into with Arvinas Operations, Inc.
We executed a non-exclusive license agreement for internal research with Arvinas Operations, Inc. (Connecticut, U.S.A.) to access iPS cell r...
License-Out
License Agreement has been entered into with Anatomic Incorporated
We have executed a non-exclusive license agreement with Anatomic Incorporated (Minneapolis, MN, U.S.A.). With this license, Anatomic will be...
License-Out
License Agreement has been entered into with Cytochroma Limited
We have executed a non-exclusive license agreement with Cytochroma Limited (Edinburgh, U.K.) for allowing them to sell iPS cell-derived cell...
License-Out
License Agreement Has Been Entered into with Rege Nephro Co.,Ltd.
We have executed a worldwide license agreement with Rege Nephro Co.,Ltd. (Kyoto, Japan) for development and provision of regenerative medici...
License-Out
License Agreement Has Been Entered into with ReGen Theranostics, Inc.
We have executed a license agreement with ReGen Theranostics, Inc. (Rochester, MN, U.S.A.) for the use of iPS cell-derived cardiomyocytes pr...
